Articles Focus on CBD Hemp Oil RSHO-X™ Recovery Story of Adolescent Mexico Girl Emili Zoe
San Diego, CA – Sept. 15, 2016 – Medical Marijuana, Inc. (OTC: MJNA) announced today that the Company garnered national news headlines across Mexico, including a Reforma article about how adolescent Mexico girl Emili Zoe found Real Scientific Hemp Oil-X™ (RSHO-X™), the first legal cannabis product in Mexico.
The Reforma article “No más convulsiones para Emili” explains how Emili Zoe, an adolescent from Mexico, and her family toiled and tirelessly researched to eventually find Medical Marijuana, Inc.’s RSHO-X™.
“We are proud that our cannabidiol (CBD) hemp oil product, without THC, is the first-ever cannabis-based (the hemp type of cannabis) product to be approved by the federal authorities in Mexico for import,” said Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus. “It’s so amazing to watch the national news media in Mexico cover this story, and it’s heart-warming to our hard-working team to hear the story of Emili Zoe and her family that we now feel are part of our Company’s family. We are blessed to have such a brave individual and dedicated family as part of our lives.”
Other major national Mexico outlets that have reported on Emili’s story using RSHO-X™ include:
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: [email protected]